3-183071223-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_020166.5(MCCC1):c.626G>A(p.Gly209Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G209G) has been classified as Likely benign.
Frequency
Consequence
NM_020166.5 missense
Scores
Clinical Significance
Conservation
Publications
- 3-methylcrotonyl-CoA carboxylase 1 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- 3-methylcrotonyl-CoA carboxylase deficiencyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MCCC1 | NM_020166.5 | c.626G>A | p.Gly209Asp | missense_variant | Exon 6 of 19 | ENST00000265594.9 | NP_064551.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MCCC1 | ENST00000265594.9 | c.626G>A | p.Gly209Asp | missense_variant | Exon 6 of 19 | 1 | NM_020166.5 | ENSP00000265594.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251464 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461858Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
3-methylcrotonyl-CoA carboxylase 1 deficiency Uncertain:2
- -
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 209 of the MCCC1 protein (p.Gly209Asp). This variant is present in population databases (rs186209189, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with MCCC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 569048). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
MCCC1-related disorder Uncertain:1
The MCCC1 c.626G>A variant is predicted to result in the amino acid substitution p.Gly209Asp. To our knowledge, this variant has not been reported in the literature. A different substitution affecting the same amino acid (p.Gly209Ala) was reported along with a loss-of-function variant in a patient with 3-MCC deficiency (Yang et al. 2015. PubMed ID: 25382614). Of note, the p.Gly209 amino acid is located in the enzyme ATP binding pocket (Yang et al. 2015. PubMed ID: 25382614). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-182789011-C-T). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at